ESC 365 - Evolution of cardiovascular risk factors, analytical markers and functional capacity. Are the benefits of phase II of the cardiac rehabilitation program maintained in phase III?

EAPC Premium Access

Evolution of cardiovascular risk factors, analytical markers and functional capacity. Are the benefits of phase II of the cardiac rehabilitation program maintained in phase III?

Session: Poster Session 2 - Risk Factors and Prevention - Secondary Prevention

Topic: Secondary Prevention

Speaker: Mrs B. Garcia Magallon (Guadalajara, ES)

Event: EuroPrevent 2019

Congress Presentation

Add to my library

About the speaker

Mrs Belen Garcia Magallon

Guadalajara University Hospital, Guadalajara (Spain)

0 follower

30 more presentations in this session

Application for cardiac self-Improvement(ANSIM), a randomized controlled trial: 9-month clinical outcome

Speaker: Doctor J. Kim (Seoul, KR)

Do women with cardiovascular disease respond differently to aerobic interval training? Exploring the interaction between sex and exercise modality on psychological and cardiomtabolic health

Speaker: Doctor T. Terada (Nottingham, GB)

A randomized trial of an exercise maintenance intervention after cardiac rehabilitation

Speaker: Doctor R. Reid (Ottawa, CA)

Effects of a community-based lifestyle intervention in older patients with coronary artery disease: results from the RESPONSE-2 trial

Speaker: Miss P. Jepma (Amsterdam, NL)

Admission cardiac troponin T improves risk stratification of patients with ST elevation myocardial infarction

Speaker: Doctor J. Coelho Lima Junior (Cambridge, GB)

Access the full session

Poster Session 2 - Risk Factors and Prevention - Secondary Prevention

Speakers: Mrs B. Garcia Magallon, Doctor J. Kim, Doctor T. Terada, Doctor R. Reid, Miss P. Jepma...

About the event

EuroPrevent 2019

11 April - 13 April 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources